Adverse reactions during voluntary donation of blood and/or blood components. A statistical-epidemiological study

Blood Transfusion

Volumn 5, Issue 3, 2007, Pages 143-152

  Crocco, Antonio ^a,b   D'Elia, Domenico ^a  

^a MISERICORDIA E DOLCE HOSPITAL   (Italy)

^b Azienda Ospedaliera di Prato   (Italy)

Author keywords

Adverse reactions; Blood donations; Blood donors

Indexed keywords

ADRENALIN; ATROPINE; CORTICOSTEROID; HYPERTENSIVE FACTOR;

ADULT; AGED; APHERESIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL FEATURE; COLLOID; CONTROLLED STUDY; CRYSTALLOID; FEMALE; HUMAN; MALE; OXYGEN THERAPY; PLASMA; THROMBOCYTE;

EID: 47749134873     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2007.0005-07     Document Type: Article

References (31)

1. Winters JL. Complications of donor apheresis. J Clin Apher 2006; 21: 132-41.
2. Danic B, Gouezec H, Bigant E, et al. Incidents of blood donation. Transfus Clin Biol 2005; 12: 153-9.
3. van Jaarsveld H, Pool GF. Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein. Atherosclerosis 2002; 161: 395-402.
4. Bern MM, Bierbaum BE, Katz JN, et al. Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty. Transfus Med 2006; 16: 313-9.
5. Tsuboi S, Tamura Y, Fujibayashi T, et al. Hemagglutination of preoperative blood donation in patients with rheumatoid arthritis. Mod Rheumatol 2004; 14: 77-81.
6. Schulzki T, Seidel K, Storch H, et al. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA). Vox Sang 2006; 91: 162-73.
7. Newman BH, Newman DT, Ahmad R, Roth AJ. The effect of whole-blood donor adverse events on blood donor return rates. Transfusion 2006; 46: 1374-9.
8. France CR, France JL, Roussos M, et al. Mild reactions to blood donation predict a decreased likelihood of donor return. Transf Apher Sci 2004; 30: 17-22.
9. Zervou EK, Ziciadis K, Karabini F, et al. Vasovagal reactions in blood donors during or immediately after blood donation. Transfus Med 2005; 15: 389-94.
10. Newman BH. Blood donor complications after whole-blood donation. Curr Opin Hematol 2004; 11: 339-45.
11. Newman BH. Vasovagal reaction rates and body weight: findings in high- and low-risk populations. Transfusion 2003; 43: 1084-8.
12. Guerra MJ, Vaz MJ, Silva O. Adverse reactions of blood donation. Servir 2002; 50: 232-5.
13. Tomita T, Takayanagi M, Kiwada K, et al. Vasovagal reactions in apheresis donors. Transfusion 2002; 42: 1561-6.
14. Newman BH, Pichette S, Pichette D, Dzaka E. Adverse effects in blood donors after whole-blood donation: a study of 1000 blood donors interviewed 3 weeks after whole-blood donation. Transfusion 2003; 43: 598-603.
15. Hanson SA, France CR. Predonation water ingestion attenuates negative reactions to blood donation. Transfusion 2004; 44: 924-8.
16. Karger R, Slonka J, Junck H, et al. Extracorporeal blood volume of donors during automated intermittent-flow plasmapheresis and its relevance to the prevention of circulatory reactions. Transfusion 2003; 43: 1096-106.
17. Carrasquilla G. Immediate adverse reactions to donation: frequency and characterization, Biomedica 2001; 21: 224-7.
18. Perseghin P, Capra M, Baldini V, et al. Bradykinin production during donor plasmapheresis procedures. Vox Sang 2001; 81: 24-8.
19. Committee on trauma. Advanced trauma life support student manual. Chicago: American College of Surgeons, 1989:57.
20. Strauss RG. Mechanisms of adverse effects during hemapheresis. J Clin Apher 1996; 11: 160-4.
21. Ditto B, France CR. Vasovagal symptoms mediate the relationship between predonation anxiety and subsequent blood donation in female volunteers. Transfusion. 2006; 46: 1006-10.
22. Krumholz A, Ness PM, Hauser WA, et al. Adverse reactions in blood donors with a history of seizures or epilepsy. Transfusion 1995; 35: 470-4.
23. Ogata H, Iinuma N, Nagashima K, et al. Vasovagal reactions in blood donors. Transfusion 1980; 20: 679-83.
24. Gorodetskii VM. Reactions observed in blood donors and patients during cytapheresis on the blood cell separator. Ter Arkh 1978; 50: 129-31.
25. Ingerslev J. Safety of plasma derivatives. Haemostasis 1994; 24: 311-23.
26. Bellitti P, Valeriano R, Gasperi M, et al. Cortisol and heart rate changes in first- and fourth-time donors. Vox Sang 1994; 67: 42-5.
27. Westphal RG. Health risks to cytapheresis donors. Clin Haematol 1984; 13: 289-301.
28. Pisciotto P, Sataro P, Blumberg N. Incidence of adverse reactions in blood donors taking antihypertensive medications. Transfusion 1982; 22: 530-1.
29. Sandler SG, Nusbacher J. Health risk of leukapheresis donors. Haematologia (Budap) 1982; 15: 57-69.
30. Bonomo P, Garozzo G, Bennardello F. The selection of donors in multicomponent collection management. Transfus Apher Sci 2004; 30: 55-9.
31. Despotis GJ, Goodnough LT, Dynis M, et al. Adverse events in platelet apheresis donors: a multivariate analysis in a hospital-based program. Vox Sang 1999; 77: 24-32.